$13.24+4.0%Nov 13 close
Figures through October 3, 2026, from the 10-Q filed November 12, 2026
| Measure | 3 months toOct 3, 2026 | 3 months toSep 27, 2025 | Change |
|---|---|---|---|
| Total Revenue | $205.9M | $213.7M | -3.64% |
| Profit | -$5.6M | -$6.5M | +14.81% |
| Profit per share | -$0.30 | -$0.36 | +16.67% |
| Free Cash Flow | $8.4M | -$5.2M | +263.66% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
“As we continue our transformation to an omnichannel health and wellness company, our third quarter results were mixed, with meaningful improvement in some areas and results that fell short of our expectations in others,”
Quoted verbatim from the release, and shown only when the filing attributes it to a named person.
Releases land before the open or after the close, so the window runs from the close before the report day to the close of the session after it — the reaction is inside it either way.
USANA develops and manufactures high-quality nutritional supplements, functional foods and personal care products that are sold directly to Brand Partners and Preferred Customers across 25 global markets. More information on USANA can be found at www.usana.com. USANA also owns a 78.8% controlling ownership stake in Hiya Health Products, a children's health and wellness company, and a 100% interest in Rise Wellness. Hiya and Rise Wellness offer a variety of clean-label health products. More information on Hiya can be found at www.hiyahealth.com . More information on Rise Wellness can be found at www.risebar.com and www.proteinpop.com . Investor
The company’s own description, as it appears at the foot of the release.
The quote and the company description come from Usana Health Sciences, Inc.’s Item 2.02 8-K filed November 3, 2026; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.
Usana Health Sciences, Inc. reported on November 3, 2026. We are fetching the call transcript; its summary follows once the transcript is in.
Just reported
From Usana Health Sciences, Inc.'s results release of November 3, 2026; its quarterly report has since been filed.
Actual
$205.9M
-3.6% y/y
-7.8% q/q
Guided
—
No guide given
Actual
-$0.30
Guided
—
No guide given
Actual
-$1.4M
Guided
—
No guide given
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.